Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Crisafulli

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Seminars in Arthritis and Rheumatism|January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registriesFrancesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism|March 30, 2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registryAntonio Vitale, Valeria Caggiano, Eduardo Martin-Nares, et al.
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
Frontiers in Medicine|July 3, 2023
A patient-driven registry on Behçet's disease: the AIDA for patients pilot projectCarla Gaggiano, Alessandra Del Bianco, Jurgen Sota, et al.
Rheumatology (Oxford, England)|September 30, 2025
Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease RegistryLaura Calabrese, Martina D'Onghia, Alessandra Cartocci, et al.
Frontiers in Medicine|August 14, 2025
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registryJurgen Sota, Germán Mejía-Salgado, Silvana Guerriero, et al.
Ocular Immunology and Inflammation|May 17, 2024
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory DisordersJurgen Sota, Silvana Guerriero, Giuseppe Lopalco, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Seminars in Arthritis and Rheumatism|January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registriesFrancesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism|March 30, 2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registryAntonio Vitale, Valeria Caggiano, Eduardo Martin-Nares, et al.
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
Frontiers in Medicine|July 3, 2023
A patient-driven registry on Behçet's disease: the AIDA for patients pilot projectCarla Gaggiano, Alessandra Del Bianco, Jurgen Sota, et al.
Rheumatology (Oxford, England)|September 30, 2025
Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease RegistryLaura Calabrese, Martina D'Onghia, Alessandra Cartocci, et al.
Frontiers in Medicine|August 14, 2025
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registryJurgen Sota, Germán Mejía-Salgado, Silvana Guerriero, et al.
Ocular Immunology and Inflammation|May 17, 2024
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory DisordersJurgen Sota, Silvana Guerriero, Giuseppe Lopalco, et al.
Pageof 6